More than 130 suppliers
ISO certified
In-house tech support
we Connect you
Bio-Connect
ProductsBack/SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9]

SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9]

GTX632604
GeneTex
ApplicationsElectron Microscopy, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request
More than 130 suppliers
ISO certified
In-house tech support

Overview

  • Supplier
    GeneTex
  • Product Name
    SARS-CoV / SARS-CoV-2 (COVID-19) spike antibody [1A9]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. ICC/IF: 1:100-1:2000. IHC-P: 1:100-1:500. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Electron Microscopy, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    1A9
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Mouse
  • Isotype
    IgG1
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Kachko A, Selvaraj P, Liu S, et al. Vaccine-associated respiratory pathology correlates with viral clearance and protective immunity after immunization with self-amplifying RNA expressing the spike (S) protein of SARS-CoV-2 in mouse models. Vaccine. 2024,42(3):608-619. doi: 10.1016/j.vaccine.2023.12.052
    Read this paper
  • Hagelauer E, Lotke R, Kmiec D, et al. Tetherin Restricts SARS-CoV-2 despite the Presence of Multiple Viral Antagonists. Viruses. 2023,15(12). doi: 10.3390/v15122364
    Read this paper
  • Dey D, Qing E, He Y, et al. A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs. Nat Commun. 2023,14(1):8358. doi: 10.1038/s41467-023-44076-3
    Read this paper
  • Roessler J, Pich D, Krähling V, et al. SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests. Biomedicines. 2023,11(11). doi: 10.3390/biomedicines11112892
    Read this paper
  • Styles CT, Zhou J, Flight KE, et al. Propylene glycol inactivates respiratory viruses and prevents airborne transmission. EMBO Mol Med. 2023,15(12):e17932. doi: 10.15252/emmm.202317932
    Read this paper
  • Angioni R, Bonfanti M, Caporale N, et al. RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity. Cell Rep Med. 2023,4(11):101266. doi: 10.1016/j.xcrm.2023.101266
    Read this paper
  • Streblow DN, Hirsch AJ, Stanton JJ, et al. Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology. Nat Commun. 2023,14(1):7062. doi: 10.1038/s41467-023-42440-x
    Read this paper
  • Lécuyer D, Nardacci R, Tannous D, et al. The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection. Front Immunol. 2023,14:1270081. doi: 10.3389/fimmu.2023.1270081
    Read this paper
  • Carvalhal F, Magalhães AC, Rebelo R, et al. Evaluation of the Cytotoxic and Antiviral Effects of Small Molecules Selected by In Silico Studies as Inhibitors of SARS-CoV-2 Cell Entry. Molecules. 2023,28(20). doi: 10.3390/molecules28207204
    Read this paper
  • Yang CF, Liao CC, Hsu HW, et al. Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission. J Biomed Sci. 2023,30(1):87. doi: 10.1186/s12929-023-00980-w
    Read this paper

Datasheet

Download Datasheet

FAQ

Go to our frequently asked questions